fda on bpc 157 panel backs compounded BPC-157, KPV peptides in win for RFK Jr This is the first vote
This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the FDA will make Hims & Hers gains as FDA panel endorses peptide BPC 157 (HIMS) Seeking Alpha FDA Advisers Vote to Ease Restrictions on BPC 157, TB 500, and Other Novel Peptides Glitchwire Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest BPC 157 Legal Status: FDA Regulations and Compounding
Pay in 4 interest-free payments of $7.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



